Replies to post #429445 on NorthWest Biotherapeutics Inc (NWBO)

[X Master]

Flipper, there is one more criteria that one utilizes for evaluation;
A speculative company invests a bulk of its resources into higher-risk growth projects. Investing in a speculative company, on the other hand, need not be viewed as a high-risk investment, especially if that company has established a credible and successful, business model.

NWBO has no track record. This said, I believe Merck (or someone else) has figured out NWBO’s speculative value and now NWBO is within a second quiet period. We will see soon.

[eagle8]

Once we've had a TLD+ publication (and maybe something about approval UK), but especially an uplist, the world will appreciate the company's potential.
At that point, the bear is definitely loose.
imo.

Thanks for all your contributions this year flipper.
We are in the same camp thankfully.

All the best to you and yours and beyond HAPPY CHRISTMAS.

GLTU

[Hopeforthefuture3]

Flipper, I was certainly involved in that speculative run-up in early 2015. My purchases were fueled by papers from Liau and ucla and in large part from the ceo saying good things and that we were on the home stretch. It has been a long 'home stretch' and a new definition of the term 'soon'. I hope that 2022 will at long last be the year we get another speculative run, this time based on results. Year 2021 has not been good for the stock price, started the year a little over 1.50 and as of now has lost about half its value. General market up 25%. Market flat so far in December and in last month nwbo has come from about a dollar to 76 cents. Thank goodness I have a diverse portfolio. I hope all the breadcrumbs we have been getting lead to a dramatic change in valuation once results are finally out. Just hope the january 20th presentation from Bosch will have material news if not before then.
Happy holiday to both long and short
Stay tuned....

[lrdpdx77]

I agree with what you're saying and I think a SP of $5 to $10 would reflect a great deal of speculative value pre-approval. I think SP after approval could easily be $20 or greater. Now if TLD/Publication results leads significant parts of the market to assign a higher probability to approval then my initial $5 to $10 range is too low. I feel pretty strongly that we should be have some RA approvals by June 2022 so I expect the price to be in the higher ranges ($20 plus) for the second half of 2022.